These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 3105908

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Thyrotropin releasing hormone: autonomic effects upon cardiorespiratory function in endotoxic shock.
    Holaday JW, Faden AI.
    Regul Pept; 1983 Oct; 7(2):111-25. PubMed ID: 6419292
    [Abstract] [Full Text] [Related]

  • 6. Effects of naloxone on hemodynamics, oxygen transport, and metabolic variables in canine endotoxin shock.
    Thijs LG, Balk E, Tuynman HA, Koopman PA, Bezemer PD, Mulder GH.
    Circ Shock; 1983 Oct; 10(2):147-60. PubMed ID: 6839424
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Beta-adrenergic-dependent and -independent actions of naloxone on perfusion during endotoxin shock.
    Dziki AJ, Lynch WH, Ramsey CB, Law WR.
    Circ Shock; 1993 Jan; 39(1):29-38. PubMed ID: 8386986
    [Abstract] [Full Text] [Related]

  • 10. [Effects of thyrotropin releasing hormone (TRH) on endocrine function during endotoxin shock in dogs].
    Kudo M, Kudo T, Matsuki A, Oyama T.
    Masui; 1987 Jun; 36(6):948-55. PubMed ID: 2821299
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Augmented venous return: a model of left ventricular afterload reduction during the course of endotoxin shock.
    Hess ML, Krause SM, Komwatana P, Eaton R, Okabe E.
    Circ Shock; 1981 Jun; 8(4):435-50. PubMed ID: 7023737
    [Abstract] [Full Text] [Related]

  • 13. The effects of vasoactive mediator antagonists on endotoxic shock in dogs. I.
    Toth PD, Hamburger SA, Judy WV.
    Circ Shock; 1984 Jun; 12(4):277-86. PubMed ID: 6722995
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of thyrotropin releasing hormone as a therapeutic intervention for endotoxemia.
    Brackett DJ, Schaefer CF, Lerner MR, Holaday JW, Fagraeus L, Wilson MF.
    Regul Pept; 1990 Jul 30; 29(2-3):153-62. PubMed ID: 2120745
    [Abstract] [Full Text] [Related]

  • 15. The effects of prostacyclin (PGI2) on endotoxin shock and endotoxin-induced platelet aggregation in dogs.
    Fletcher JR, Ramwell PW.
    Circ Shock; 1980 Jul 30; 7(3):299-308. PubMed ID: 7004660
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A pharmacological study of the cardiovascular effects of TRH-T in haemorrhagic shock in rats.
    Guarini S, Gherardi S, Calabrò G, Bertolini A.
    Arch Int Pharmacodyn Ther; 1989 Jul 30; 299():65-76. PubMed ID: 2505701
    [Abstract] [Full Text] [Related]

  • 18. Hemodynamics in experimental endotoxin shock with continuous administration.
    Takekawa K, Sakanishi N, Tsunoda Y, Ikezono E.
    Bull Tokyo Med Dent Univ; 1983 Sep 30; 30(3):55-61. PubMed ID: 6589083
    [Abstract] [Full Text] [Related]

  • 19. Cardiovascular improvement due to RA642, a pyrimido-pyrimidine derivative, in canine endotoxin shock.
    Koyama S.
    Circ Shock; 1984 Sep 30; 13(4):341-51. PubMed ID: 6478548
    [Abstract] [Full Text] [Related]

  • 20. Cardiovascular mechanisms of thyrotropin-releasing hormone against experimental hemorrhagic shock.
    Zheng D, Chen HS, Hu DY.
    Circ Shock; 1992 Mar 30; 36(3):169-73. PubMed ID: 1611701
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.